By activating the Keap1/Nrf2 signaling pathway, NCI-H835 cells effectively mitigated the production of ROS and the consequent DNA damage that AXI could potentially induce, as observed in other tumor cell lines (45, 72). Here, NFE2L2 is linked to neoplasm.